We explored the biodistribution of NT3 protein using a second cohort of sham and stroke rats treated with either AAV1-hNT3 or AAV1-EGFP, and killed at 4 days or 8 weeks after stroke. The gene discussed is NTF3; the disease is stroke disorder.